Cell BiologybioRxivPreprint
Parkinson's disease linked LRRK2 G2019S drives oxidative nuclear DNA damage and PARP1 hyperactive signaling
Jennifer Liu, Claudia P. González-Hunt, Tara Richbourg…·Laurie H. Sanders
This study shows that the LRRK2 G2019S mutation causes oxidative nuclear DNA damage and PARP1 hyperactivation, leading to cellular vulnerability in Parkinson's disease.
DOI 10.64898/2026.02.27.708379